Laura M. Yee - Concepedia

Author

Laura M. Yee

National Cancer Institute ORCID

Also Known As

L. Yee, L.M. Yee, Laura M Yee, Laura M. Yee, Laura Yee, Lim Guat Yee, Loo Min Yee, Yee, Laura

Publications

875

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute University of Washington National Institutes of Health University of Pittsburgh Albert Einstein College of Medicine

About

Laura M. Yee is an author at National Cancer Institute specializing in translational medicine, medicine, and biomarker research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	70
2	Public Health	1	1	33
3	Biostatistics	1	1	33
4	Epidemiology	1	1	33
5	Immunology	1	1	37

Laura M. Yee

Publications

820

Citations

H-Index

Page 1

	Year	Citations
Atrial Fibrillation and the Risk of Sudden Cardiac Death Lin Y. Chen, Nona Sotoodehnia, Petra Bůžková, JAMA Internal Medicine	2012	217
Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project Diana Merino Vega, Laura M. Yee, Lisa M. McShane, Annals of Oncology	2021	174
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC’s Analytical Variables Working Group James H. Godsey, Angela Silvestro, J. Carl Barrett, Clinical Chemistry	2020	92
Can a Healthy Lifestyle Compress the Disabled Period in Older Adults? Mini E. Jacob, Laura M. Yee, Paula Diehr, Journal of the American Geriatrics Society	2016	68
Measures of Body Size and Composition and Risk of Incident Atrial Fibrillation in Older People Maria Karas, Laura M. Yee, Mary L. Biggs, American Journal of Epidemiology	2016	38
Multi-attribute method performance profile for quality control of monoclonal antibody therapeutics Zhiqi Hao, Benjamin Moore, Chengfeng Ren, Journal of Pharmaceutical and Biomedical Analysis Translational MedicineImmunocytochemical TechniqueMonoclonal Antibody TherapeuticsImmunologyTherapeutic Efficacy	2021	37
Serum Carboxymethyl-Lysine, Disability, and Frailty in Older Persons: The Cardiovascular Health Study Heather E. Whitson, Alice M. Arnold, Laura M. Yee, The Journals of Gerontology Series A	2013	36
Biomarkers in Early-Phase Trials: Fundamental Issues Laura M. Yee, Tracy Lively, Lisa M. McShane Bioanalysis Analytical ValidationFundamental IssuesBiomarker (Medicine)Translational MedicineBiomarker Test	2018	33
Molecular genomic features associated with <i>in vitro</i> response of the NCI‐60 cancer cell line panel to natural products Julia Krushkal, Simarjeet Negi, Laura M. Yee, Molecular Oncology	2020	21
Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health P. Mickey Williams, Thomas Forbes, Steven P. Lund, JCO Precision Oncology	2021	20

Page 1